Immunotherapy boosts survival of advanced Hodgkin lymphoma in clinical trial
A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92%, suggesting a new standard therapy for the…